FdaApplication

NDA 020685

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMERCK SHARP AND DOHME CORP
application_typeNDA
approval_date1996-03-13

Products (4)

ProductActive ingredientStrengthDosage form
CRIXIVANINDINAVIR SULFATEEQ 100MG BASECAPSULE;ORAL
CRIXIVANINDINAVIR SULFATEEQ 200MG BASECAPSULE;ORAL
CRIXIVANINDINAVIR SULFATEEQ 333MG BASECAPSULE;ORAL
CRIXIVANINDINAVIR SULFATEEQ 400MG BASECAPSULE;ORAL

4 products